HNB
WGS icon

Huntington National Bank’s GeneDx Holdings WGS Stock Holding History

Huntington National Bank’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321 Buy
5
+4
+400% +$365 ﹤0.01% 2476
2025
Q4 		$130 Hold
1
– – ﹤0.01% 2483
2025
Q3 		$108 Buy
+1
New +$109 ﹤0.01% 2603

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Huntington National Bank's WGS Position: Q1 2026 in Review

Huntington National Bank increased its GeneDx Holdings (WGS) stake by 400% in Q1 2026, buying an estimated $365 and bringing the position to 5 shares worth $321. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

Huntington National Bank first reported a position in WGS in Q3 2025 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Huntington National Bank held 5 shares of GeneDx Holdings worth $321 as of Q1 2026.
  • Huntington National Bank bought 4 GeneDx Holdings shares in Q1 2026, an estimated $365.
  • GeneDx Holdings made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2476 holding.
  • Huntington National Bank first reported a position in GeneDx Holdings in Q3 2025 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.